Home
Home
About NYBA
About NYBA
Mission Statement
Board of Directors
Publication
Publication
Annual Reports
Speeches,Letters, Presentations
Annual Meeting Archive
NYBA Survey
Purchasing Consortium
Member Directory
Public Policy
Public Policy
NYBA Action
Industry Issues & Initiatives
Calendar
Calendar
Submit Event
NYBA Annual Meeting
Registration
Meeting Sponsor's Page
Sponsorships and Advertising Opportunities
Press Room
Press Release
Press Release
Press Release Archive
NYBA in the News
Member News
Member News
Stories pages
Life Sciences News(Businesswire)
Newsletter
Newsletter
Newsletter Archive
New York Biotech Center
New York Biotech Center
New York's Biotech Strengths
New York Biotech Initiatives
New York Biotech Initiatives
NYSTAR
Research & Development Where in New York
Research & Development Where in New York
Tech Transfer Directory
Academic Facilities
Incubators & Tech Parks
Sources of Funding
Government Economic Development Offices
Patent Advocacy Groups
NYBA Biotechnology Genealogy Database
NYBA's New York BioWeb
NYBA's New York BioWeb
Submit Link Form
Join NYBA
Join NYBA
Benefits of Membership
Application
Purchasing Consortium
Sponsorships and Advertising Opportunities
Member Directory
Careers
Search Openings
Search Resumes
Submit Resume
Submit Job
Job Profiles
Member Directory
Notices
Contact Us
Site Map
New York Biotechnology Association Announces Search For New Executive Director
The New York Biotechnology Association (NYBA), a not-for-profit trade...
06/ 29/ 2007
More…
New York Biotechnology Headlines
Today is July 24, 2008. All times in Eastern Daylight Time.
07/24/2008 - 08:30 AM
Cornerstone Pharmaceuticals Announces Approval to Conduct Phase I/II Clinical Trial of CPI-613 in Cancer Patients by US FDA
07/24/2008 - 07:00 AM
Antigenics to Report Second Quarter 2008 Financial Results on July 31, 2008; Conference Call to Follow
07/24/2008 - 02:00 AM
Elan Reports Second Quarter 2008 Financial Results
07/23/2008 - 04:30 PM
Biodel Announces Publications Demonstrating Superior Metabolic Profile of VIAject(TM) Compared to the Rapid-acting Analog Humalog(R) and Regular Human Insulin in Healthy Volunteers and Compared to Regular Human Insulin in Patients with Type 1 Diabetes
07/23/2008 - 04:05 PM
OSI Pharmaceuticals Announces Second Quarter 2008 Financial Results
07/23/2008 - 12:24 PM
Research and Markets: Recent Report 'Chugai Pharma Partnering Guide 2008' Provides A Firm Basis for Initial Due Diligence into Chugai as A Prospective Partner Company
07/23/2008 - 10:00 AM
Vertical*i Achieves Record Growth in Sales Orders for the First Half of 2008
07/23/2008 - 08:30 AM
Drug Topics Examines the Emerging Arm of Innovation at Retail Pharmacies
07/23/2008 - 08:00 AM
Allos Therapeutics to Present at the Bank of America 2008 Specialty Pharmaceuticals Conference
07/23/2008 - 08:00 AM
The Medicines Company Reports Second Quarter and First Half 2008 Financial Results and Raises Full Year Top Line Guidance
07/23/2008 - 06:30 AM
AngioDynamics Appoints Vice President of International IRE Sales
07/22/2008 - 04:00 PM
BioScrip to Present at BMO Capital Markets' Focus on Healthcare Conference
07/22/2008 - 10:26 AM
Compliance for Life(TM) Medication Dosing Reminders Go Global
07/22/2008 - 03:06 AM
PhiloGene, Inc. Announces that VEGFb(TM) has been Granted Orphan Drug Designation by the FDA for the Treatment of Advanced Melanoma
07/22/2008 - 02:00 AM
Elan and Wyeth Announce Webcast To Discuss Bapineuzumab Phase 2 Clinical Trial Results
07/21/2008 - 11:19 AM
Pawfect Foods Announces Acquisition of Synergy Pharmaceuticals and $3.0 Million Financing
07/21/2008 - 10:18 AM
Vyteris, Inc. Receives $2.5 Million Loan from Ferring Pharmaceuticals, Inc.
07/21/2008 - 09:00 AM
Lakewood Pathology Associates Announces New Name
07/21/2008 - 09:00 AM
AMRI Expands Laboratory Capacity in Singapore; Adds In Vitro Biology Laboratory
07/21/2008 - 07:00 AM
VioQuest Pharmaceuticals Appoints Christopher P. Schnittker, CPA, as Chief Financial Officer
07/21/2008 - 07:00 AM
IMS Health Delivers 12 Percent Revenue and 11 Percent Operating Income Growth in Second Quarter
07/18/2008 - 04:30 PM
ImClone Systems to Host Second Quarter 2008 Financial Results Conference Call
07/18/2008 - 02:14 PM
The Multiple Myeloma Research Consortium (MMRC) Announces the Initiation of Phase I/II Study of Elotuzumab (Huluc63) Monoclonal Antibody in Combination with Velcade
07/18/2008 - 11:07 AM
Discover the Relevance of Hippocampal Place Fields to Learning and Memory
07/18/2008 - 08:00 AM
Omrix Biopharmaceuticals Announces Second Quarter 2008 Financial Results Date and Conference Call
1
2
NEXT »
Terms of Use
|
©2008 Business Wire
© 2007 New York Biotechnology Association
HOME
|
ABOUT NYBA
|
CONTACT US
|
NOTICES
|
SITE MAP
Website by Axxiem